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Abstract:  Irritable bowel syndrome (IBS) is a large bowel functional disorder characterized by abdominal pain or 
discomfort and is associated with bowel habit changes without organic disorder. IBS is affected by many 
factors and is suspected of involving central and peripheral mechanisms, such as gastrointestinal 
dysmotility, bowel visceral/mucosal hypersensitivity, increased bowel permeability and interaction among 
the luminal factors including food and bowel microbiota changes, bowel epithelial barrier, mucosa 
immunity, genetic factor and biopsychosocial and brain gut axis which are suspected to affect IBS 
pathophysiology. Understanding the various factors and mechanisms underlying IBS helps in the 
consideration of management and repair of patients’ prognosis. 
1 INTRODUCTION 
Irritable bowel syndrome (IBS) is a functional 
abnormality of the large bowel characterized by 
abdominal pain or discomfort and is associated with 
bowel habit changes without organic abnormalities. 
IBS patients’ various complaints and the absence of 
certain diagnostic markers make clinical 
presentation crucial in establishing IBS diagnosis 
(Owyang, 2009).  
Worldwide, IBS occurs in 3.6% - 21.8% of the 
population with an average of 11%. In the United 
States, the incidence of IBS reaches 15% of the 
population, in Asia the prevalence is between 2.9% - 
15.6% of the population, while in Indonesia there is 
no documentation of the number of IBS incidents. 
Women are known to have more IBS than men with 
the ratio of 3:1 (Sperber, 2010; Mearin et al., 2012; 
Manan, 2014). 
IBS can occur at various ages, but its prevalence 
decreases with age. At least 50% of IBS patients 
experience early symptoms before the age of 35 and 
it rarely occurs at the age of above 60 years where 
more organic abnormalities are found (Mach, 2004). 
IBS has a high social impact in the community and 
is influential in decreasing the quality of life. In the 
United States, IBS is the most common digestive 
disease with an average of 10.6 visits per year and 
requires high health costs. About 2 million 
prescriptions are given out by doctors to IBS 
patients and spend approximately $742 per year 
(Owyang 2009; Sperber, 2010).  
The pathophysiology of IBS remains unknown 
for certain to date. Genetic factors, intestinal 
microbiota, intestinal dysmotility, particularly 
lactose intolerance, visceral hypersensitivity, mild 
inflammation, and abnormalities of brain-gut 
interaction are suspected to underlie IBS complaints 
(Park et al., 2010; El-Salhy, 2012). Understanding 
the various factors and mechanisms underlying IBS 
helps in the consideration of the management and 
repair of patients’ prognosis. 
2 LARGE BOWEL ANATOMY 
The large bowel is a part of the lower 
gastrointestinal tract, with the length of about 1.5 m 
and diameter of 6 - 7 cm. It consists of cecum, colon, 
rectum, and anus. The ileocecal valve lies at the 
upper limit of the cecum and prevents the return of 
the fecal matter from the cecum into the small 
intestine. The appendix is located around 2.5 cm 
from the ileocecal valve. The colon consists of 
ascending, transverse, and descending colon. The 
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anal canal is between the two medial borders of the 
levator ani muscle. The sphincter muscle is able to 
withstand the occurrence of incontinence. The large 
bowel has two main functions serving as a reservoir 
of residual digestion products and water absorbance 
and electrolytes in the process of digestion (Porth, 
2011).  
3 ENTERIC AND AUTONOMIC 
NERVOUS SYSTEM 
The intramural nerves in the gastrointestinal wall 
consist of 2 plexuses, i.e. the myenteric/Auucach 
plexus and the submucosal/Meissner plexus. Both 
plexuses are connected to ganglion cells along the 
gastrointestinal wall. The myenteric plexus lies 
between the muscles of the circular and the 
longitudinal muscles, while the submucosal plexus is 
between the mucosal layer and the circular muscles.  
The activity of neurons is governed by local 
stimuli, inputs from the autonomic nervous system, 
and transmitter fibers connecting the two plexuses. 
The myenteric plexus consists of a linear chain of 
connecting neurons located along the gastrointestinal 
tract and has the biggest role in gastrointestinal 
motility. Meanwhile, the submucosal plexus works 
to regulate segmental function in the gastrointestinal 
tract by integrating signals from the mucosal lining 
to regulate intestinal motility, intestinal secretion, 
and nutrient absorption (Porth, 2011; Wood et al., 
2012).  
The gastrointestinal tract is also innervated by 
the autonomic nervous system by both the 
sympathetic and parasympathetic nerves. The 
parasympathetic nerve innervates the abdomen, 
small bowel, cecum, ascending colon, and transverse 
colon through the vagus nerve. The descending 
colon is innervated by the parasympathetic nerves 
derived from the sacral segments of the spinal cord. 
The parasympathetic preganglionic fibers will affect 
the intramural plexus and work directly on the 
intestinal smooth muscle.  Most of the 
parasympathetic fibers are excitatory components 
(Porth, 2011).  
In addition, gastrointestinal sympathetic 
innervation travels through the thoracic ganglia, 
celiac, superior mesenteric, and inferior mesenteric. 
Sympathetic control is largely mediated through 
changes in neuronal activity in the intramural 
plexus. The sympathetic nervous system acts to 
control mucosal secretions by mucosal glands, 
reducing motility by inhibiting intramural pyelid 
neuron activity, improving sphincter function, and 
improving smooth muscle tone of the 
gastrointestinal tract. The sympathetic fibers supply 
the lower esophagus, the pylorus, and the internal 
and external anal sphincters. Most are excitatory 
nerves, but their role in controlling sphincters is 
poorly understood (Porth, 2011; Wood et al., 2012). 
4 CONCEPT OF BOWEL 
PHYSIOLOGY 
There were two aspects of bowel physiology that are 
most relevant to explain the functional digestive 
disorders, i.e. sensation and motility aspects. Bowel 
mobility includes myoelectric activity, contraction, 
tone, regularity of movement, and transit periods 
governed by reflex mechanisms and is strongly 
associated with intestinal sensitivity (Browning and 
Travagli, 2014). 
4.1 Bowel Sensation Aspect 
Gastrointestinal function is controlled by the enteric 
nervous system located in the gastrointestinal wall 
and the sympathetic-parasympathetic nerves of the 
autonomic nervous system. The concept of sensation 
in the digestive system refers to the perceptual 
awareness of intestinal stimuli as well as afferent 
input on the gastrointestinal sensory pathway, both 
related to perception and reflex response. The 
activation of the vagal nerve afferent is known to 
modulate viscera pain. The stimulus of neurons from 
the afferent spine fibers and received directly by the 
spinal dorsal horn will be delivered to the 
supraspinal to the cortical regions where the 
perception of consciousness is generated. In 
addition, wobble viscera is also innervated by a 
group of spherical sensitive splanchnic afferent 
fibers (Kellow et al., 2006).  
4.2 Bowel Motility Aspect 
Bowel motility functions include propulsion along 
the gut, mixing bowel contents with digestive 
enzymes, directing the digestive product to the 
absorption surface area, preventing retrograde 
movement of intestinal contents, as well as 
removing the digestive residue. Motility is 
controlled by reflexes, both central and peripheral 
reflexes, as well as brain-gut axis. Gastrointestinal 
contractions can be classified by duration, such as 
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phasic contractions/short duration and 
tonic/continuous contractions.  
Phasic contractions play a role in the movement 
of digestive products while tonic contractions are 
beneficial in food-storing function such as in the 
proximal abdomen, large bowel, and sphincter areas. 
Communication between the various intestinal areas 
is facilitated by the transmission of myogenic and 
neurogenic longitudinal signals throughout the gut 
(Kellow et al., 2006; Browning and Travagli, 2014). 
Motility of the gastrointestinal tract moves 
rhythmically continuously to encourage food 
products to move in the gastrointestinal tract. The 
smooth muscle provides contraction strength except 
on the pharynx and the upper third of the esophagus. 
Gastrointestinal motility is stimulated by incoming 
food or resulting from gastrocolic reflexes and 
gastrointestinal hormones. Impulses are generated 
by smooth muscle and are conducted from one fiber 
to another (Porth, 2011; Yan, 2015). 
The colon’s storage function causes its 
movement to differ from that of the small intestine. 
There are two types of colon movement, i.e. mixing 
motion and pushing motion. Mixing motion of each 
segment is called haustration movement because the 
movement occurs in segmented pockets or haustra. 
The haustration movement is a digging-type 
movement that results in all gastrointestinal 
materials interacting with the gastrointestinal 
mucosa. Another colonic movement is mass 
propulsion movements where most of the colon 
segments contract to produce this movement. Mass 
motion occurs for about 30 seconds, followed by a 
relaxation period of 2-3 minutes and the next 
contraction. The series of mass propulsion 
movements occur for only 10-30 minutes and only a 
few times a day. The normal defect process is 
initiated from the mass propulsion movement (Porth, 
2011; Yan, 2015).   
4.3 Hormones in the Gastrointestinal 
System 
The digestive tract is the largest endocrine organ in 
the body. The digestive tract produces a hormone 
that passes through the portal circulation to the 
general circulation, then returns to the 
gastrointestinal tract and begins to work. Hormones 
produced by the digestive tract include gastrin, 
secretin, and cholecystokinin. These hormones affect 
the motility and secretion of electrolytes, enzymes, 
and other hormones (Porth, 2011; Kellow et al., 
2006). 
 
4.4 Anus and Defecation Process 
 Under normal conditions, the anus is in a closed 
position. The anal closure is governed by the 
Kohlrausch valve, the puborectal muscles, the 
internal and external anal sphincter muscles, and the 
anal vein. Both types of sphincter muscles will have 
tonic contraction. The internal sphincter muscle is 
intrinsically stimulated by the sympathetic nerves 
(L1, L2) through the adrenoceptor signal, whereas 
the external sphincter muscle (a striated muscle) is 
stimulated by the pudendal nerve. The process of 
defecation begins with rectal ampulla excision with 
digestible material and stimulates rectum stretching, 
causing internal sphincter reflex relaxation, external 
sphincter constriction, and sensation for defecation.  
Continuous defecation sensation results in 
shortened rectum, external puborectal sphincter and 
anal relaxation, an annular contraction of the 
descending colonic circle muscles, the sigmoid 
colon, and the rectum via the S2-S4 parasympathetic 
stimulus. It is then followed by mechanical support 
in the form of increased abdominal pressure to push 
the feces out. The normal frequency of defecation is 
about 3 times a day-3 times/week and is affected by 
the fiber intake composition. The average adult 
excretes 60-80 g of feces/day and increases more 
than 200 g/day during diarrhea (Yan, 2015).  
 
4.5 Irritable Bowel Syndrome (IBS) 
IBS is a gastrointestinal disorder characterized by 
changes in bowel habit with discomfort or 
abdominal pain without structural and biochemical 
abnormalities (Saha, 2014). There are no certain 
pathognomonic specific lab tests or physical 
examinations for IBS. Thus, clinical symptoms are 
very important in the diagnosis of IBS (Bellini and 
Gambaccini, 2014).  
In 1978, Manning et al. set six simple criteria 
and had a separate interpretation to diagnose IBS 
(appendix 1). Manning criteria are known to have a 
sensitivity of 58% and a specificity of 74% (El-
Salhy 2012; Manan, 2014). 
In addition to Manning criteria, there are ROME 
criteria with higher sensitivity and specificity. The 
criteria of ROME III in 2006 are said to have a 
positive predictive value of 98% with a sensitivity of 
71% and specificity of 88% (Mach, 2004; Jung, 
2011; El-Salhy 2012). According to ROME III 
criteria, IBS was confirmed when there was no 
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organic abnormality that accompanied the 
complaints such as abdominal pain or discomfort in 
the abdomen recurring for at least 3 days/months in 
at least 3 months followed by 2 or more symptoms: 
1. Improvement of symptoms after defecation 
2. Changes in frequency of defecation 
3. Changes in the consistency of feces 
In addition, we found other symptoms that 
support IBS, such as abnormal defecation frequency 
(< 3 times per week or > 3x per day), fecal 
consistency stability, straining, incomplete feeling 
after defecation, feces mixed with mucus and 
bloating (Videlock and Chang, 2007).  
The four subgroups are IBS-C (constipation 
dominance), IBS-D (diarrhea dominance), IBS-M 
(mixture of constipation and diarrhea), and IBS-U 
(unsubtype). 
 However, due to the instability of frequent 
symptoms, subclassification changes from time to 
time may be possible (Manan, 2014).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Hardness of Lumpy Stools 
IBS-D is the most common type. This subgroup 
reflects low transit capacity of the colon. On the 
contrary, IBS-C reflects a long transit period of the 
colon. IBS-M (mixed) is where a patient has 
complaints of diarrhea episodes and constipation 
that alternate. The classification of IBS-U is 
unsubtyped if the patient's complaints are not 
sufficient to meet the criteria of other subtypes 
(Videlock and Chang, 2007; El-Salhy 2012).  
IBS also causes extraintestinal symptoms such as 
headache (23%-45%), back pain (27%-81%), fatigue 
(36%-63%), myalgia (29%-36%), dyspareunia (9%-
42%), and urinary frequency disorders (21%-61%). 
IBS patients with psychosomatic comorbids have 
more severe symptoms and are less responsive to 
treatment (Videlock and Chang, 2007).  
 
5 Pathophysiology of IBS and the 
Underlying Factors 
Despite the high prevalence of IBS, the 
pathophysiology of IBS has not been fully known 
until recently. IBS is based on many factors and is 
suspected to involve central and peripheral 
mechanisms (Bellini and Gambaccini, 2014; Soares, 
2014). The factors affecting the occurrence of IBS 
include dysmotilities, visceral hypersensitivity, post 
infection, food intake, changes in intestinal 
microbiota, genetics, and psychosomatic factors. 
The mechanism of IBS occurrence through these 
factors is simply presented in Appendix 2 (Kellow et 
al., 2006).  
5.1 Dysmotility 
Motility disorders in IBS include increased 
frequency, irregular luminal contractions, 
prolongation of transit time, and excessive motor 
responsiveness to food consumption. Motility 
disorders can be related to patients’ complaints 
(Soares, 2014).  Serotonin has a role in intestinal 
motility, including regulation of gastrointestinal 
motility, secretion and sensation. Serotonin is an 
important signaling molecule in the gut and acts on 
enterocytes, smooth muscles and enteric nerves. 
Most serotonin is produced in enterochromaffin 
cells. Serotonin activates both intrinsic and extrinsic 
primary afferent neurons to initiate peristaltic 
reflexes and secretions and transmit signals to the 
central nervous system. Some studies showed that in 
gastrointestinal functional abnormalities including 
IBS, there are abnormalities in the serotonergic 
enteric signals and result in hyperalgesia.  
Serotonin signal changes occur and cause enteric 
and extra-enteric symptoms. In diarrhea-
predominant IBS (IBS-D) there is decreased 
reuptake of serotonin, whereas in constipation-
predominant IBS (IBS-C) there is a disruption of 
serotonin signal output. Thus, the use of exogenous 
serotonin therapy agents to provide optimal 
serotonin signals may be considered in IBS therapy 
(Binienda et al., 2017; Soares, 2014). 
5.2 Visceral Hypersensitivity 
Visceral receptor hypersensitivity occurs in 
various stimuli in the intestinal wall of the intestinal 
visceral intestinal nerve and is triggered by bowel 
distention. Rectal distension in patients with IBS is 
also associated with an increase in excessive 
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cerebral cortex activity.  In addition, visceral 
hyperalgesia is also a result of certain GI mediators 
(serotonin, linins) or increased spinal nerve 
stimulation due to activation of N-methyl-D-
aspartate (NMDA) receptors (Soares, 2014). 
5.3 Food Effects 
One study found that about 64-89% of IBS patients 
reported complaints after eating certain foods. 
Approximately 93% of IBS patients feel the 
complaints 3 hours after eating, and 28% of patients 
feel the complaints 15 minutes after eating. Another 
study mentioned that some patients experience 
postprandial complaint worsening, especially after 
consuming wheat/grains, vegetables, dairy products, 
fatty foods, spicy foods, coffee, and alcohol. Lactose 
intolerance, fructose, and gluten are also said to 
aggravate IBS complaints (El-Salhy 2012; Rajilić-
Stojanović et al., 2015; Stanley et al., 2016). 
The reaction of IBS patients to certain foods is 
also associated with the intake of short-chain 
carbohydrates that are difficult to absorb. Short-
chain carbohydrates can increase osmotic pressure 
and provide a substrate for bacterial fermentation, 
thus increasing gas production, colon distention, and 
causing uncomfortable sensations.  In addition, 
excessive fiber administration can also provide 
complaints because it increases the substrate solving 
digestive products by the intestinal flora and produce 
gas. Intestinal supplements such as probiotics, 
prebiotics, synbiotics, and synthetic fibers are still 
undergoing research efforts to determine the 
possible benefits of IBS therapy (El-Salhy 2012; 
Rajilić-Stojanović et al., 2015).  
5.4  Intestinal Flora/Intestinal 
Microbiota 
 From several studies it is known that IBS 
patients have fewer amounts of Lactobacillus and 
Bifidobacterium spp compared to those without IBS. 
Intestinal flora attaches to epithelial cells and 
prevents bacterial pathogenic association with the 
epithelial cell wall, thus increasing the defense 
against pathogenic bacteria including Clostridia spp 
(El-Salhy, 2012). 
Small intestinal bacterial overgrowth (SIBO) is 
known to be associated with an increase in the 
amount and type of digestive tract bacteria. Several 
studies show controversy regarding the relationship 
between IBS and SIBO.  Studies showing the 
association between IBS and SIBO are evidenced by 
the abnormalities of the hydrogen number of IBS 
patients after receiving a number of carbohydrates 
(lactulose breath testing). Administration of 
antibiotics may cause changes in the amount of 
normal intestinal flora, resulting in the enteric 
effects of pathogenic bacteria and potential 
immunogenic effects. Some preliminary data 
suggest an improvement in IBS symptoms such as 
abdominal distension and flatulence symptoms in 
patients receiving probiotic preparations. However, 
these data still require further research (Kellow et 
al., 2006; Soares, 2014).  
A study found a decrease in the amount of 
intestinal lactobacillus in stressed mice. Several 
other studies also support the theory that the 
intestinal microbiota affect the brain-gut axis. The 
fetal microbiota in a person with IBS are different 
from those without IBS and vary according to the 
dominating symptoms (El-Salhy 2012; Kellow et al., 
2006; Soares, 2014).  
5.5 Enteric Infection/Inflammation  
IBS symptoms can be triggered by enteric infection 
and can persist for weeks, months, and years. The 
prevalence of IBS in post-acute gastrointestinal 
infection patients is about 10%-30%. IBS is also 
known to occur in 32%-46% of patients with 
ulcerative colitis and as much as 42%-60% in 
patients with Crohn's disease in remission.  
Fecal calprotectin increases significantly in these 
conditions. As many as 25% of postoperative IBS 
patients show symptoms corresponding to the IBS-D 
classification that occurred about 6 months after the 
onset of acute infection of virus, bacteria, protozoa, 
and worms. 
Significant factors affecting the occurrence of 
postinfectious IBS include female sex (4-23%), 
previous infectious diseases, prolonged healing 
periods, and history of anxiety, depression, 
somatization, and neurosis. However immune 
activation may occur in non-IBS where chronic 
inflammation affects cell histology such as 
inflammatory bowel disease, celiac disease, or 
ulcerative colitis (Kellow et al., 2006; Stanley et al., 
2016). 
Several studies have shown that inflammation 
and immune cells have an effect on the intestinal 
nervous system that regulates gastro intestinal 
motility and intestinal sensitivity. The occurrence of 
increased bowel permeability during episodes of 
acute gastroenteritis leads to inflammation and 
changes in intestinal microbiota, as well as bowel 
barrier dysfunction. In addition, idiopathic bile acid 
malabsorption can occur and an increase in 
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enteroendocrine cells containing serotonin and T 
lymphocytes. 
The lymphocyte cells release the mediator (nitric 
oxide, histamine and protease) and stimulate the 
enteric nervous system. One study showed a 
correlation between the symptoms of abdominal 
spasm in IBS in the presence of mast cells that are 
activated in the terminal ileum and colon. The 
association of mast cells with enteric nerves through 
tryptase activation of specific protease receptors on 
the sensory nerves stimulates visceral 
hypersensitivity (Soares, 2014; Stanley et al., 2016). 
Inflammatory responses especially after infection 
show an increase in CD-3 and CD-8 lymphocytes as 
well as calprotectin macrophages. This change will 
rapidly decrease, but in a few patients the symptoms 
persist. Persistent symptoms were found to increase 
the number of serotonin cells. Serotonin secretion by 
enterochromaffin cells will increase as a result of 
immune cell secretion products such as CD4 T cells. 
Furthermore, serotonin will enhance the immune 
response. Enterochromaffin cells will be associated 
with CD3, CD20, and some serotonergic receptors 
expressed by lymphocytes, monocytes, 
macrophages, and dendritic cells. In addition, 
immune cells in the small intestine and colon have 
receptors of intestinal vasoactive polypeptide (El-
Salhy, 2012).  
5.6 Impaired Intestinal Enteric Bowel 
System 
The intestinal enteric nervous system consists of two 
parts: endocrine cells scattered among the mucosal 
epithelial cells of the intestinal lumen, and 
peptidergic, serotonergic cells, and nitric oxide-
containing nerve cells from the enteric nervous 
system of the bowel wall. IBS patients exhibit a 
ghrelin-immunoreactive cell density in intestinal 
mucosa significantly lower in IBS-C patients and 
higher in IBS-D patients compared with someone 
without IBS. We also found a decrease in the 
number of neuropeptide cell expression inhibitors in 
gastric and somatostatin in patients with IBS-C and 
IBS-D.  
 Cell secretion of secretin and cholecystokinin 
(CCK) decreases in IBS-D but is normal patients in 
IBS-C. Ghrelin itself is an amino-28 peptide 
hormone found only in the abdominal tissues. 
Ghrelin is largely derived from endocrine cells in the 
abdominal mucosa-oxyntic and in small amounts in 
the small intestine, large intestine, and in the 
hypothalamus nucleus.  
Ghrelin has several functions, including a role in 
the regulation of growth hormone (GH) derived 
from the pituitary gland and acting synergistically 
with GH-releasing hormone. Ghrelin hormone is 
known to accelerate gastric emptying, small and 
large bowel motility, and has anti-inflammatory 
effects and protects the intestines (El-Salhy, 2012).  
5.7 Genetic Factor 
Researchers have begun to develop the possibility of 
molecular mechanisms in the process of IBS. 
Several studies have shown that the risk of IBS in 
monozygotic twins is 2x higher than that of 
dizygotic twins. The genetic quantities of 
polymorphism and gen-environment interactions are 
suspected to be related to IBS although most occur 
independently (Soares, 2014).  
The genetic factors involved in the pathogenesis 
of IBS are presumed to be due to the role of 
polymorphic gene coding for serotonin (SERT), 
cholecystokinin (CCK) receptor 1, anti-
inflammatory and pro-inflammatory interleukins, 
and alpha 2 adrenergic receptors (Bellini, et al., 
2014). The serotonin transporter (SERT) encodes the 
SERT protein located on chromosome 17q11.1-q12. 
Functional polymorphism is a site of insertion or 
deletion of 44 gene pairs in the SERT-gene-linked 
polymorphic region. Another study showed the 
relationship of functional polymorphism in SERT 
and IBS-D genes. In addition to the SERT 
polymorphism alleged to play a role in the 
mechanism of IBS occurrence, it turns out that the 
gene polymorphism of the CCK1 receptor CCKAR 
gene is also suspected to play a role in it (El-Salhy, 
2012).  
5.8 Psychosomatic 
The whole process comes from the dysregulation of 
a two-way interaction between the intestine and the 
enteric nervous system (brain-gut axis), modulated 
by several psychosocial factors, and environmental 
factors such as infection and inflammation. Some 
neurotransmitters are found in the brain and 
intestines that regulate gastro-intestinal activity, 
including 5-hydroxytryptamine (serotonin) and its 
receptors (Mach, 2004).  
Chronic stress significantly and consistently 
affects symptom onset and IBS exacerbation through 
sensorimotor dysfunction. A study conducted on rats 
found that psychological stress resulted in changes 
in the intestinal mucosal defense system to luminal 
bacteria and increased permeability of the intestinal 
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mucosal wall due to a cholinergic mechanism 
followed by presentation of mucus gastric mast 
cells. In addition, norepinephrine and corticotropin 
releasing factor (CRF) are also increased. The two 
types of CRF receptors are CRF-1 receptors that 
mediate an increase in colon contractility and CRF-2 
mediating gastric hypomotilities when high stress 
occurs (Kellow et al., 2006).  
6 CONCLUSION 
Irritable bowel syndrome (IBS) is a functional 
abnormality of the large bowel characterized by 
abdominal pain or discomfort and is associated with 
bowel habit changes without organic abnormalities. 
There were two aspects of bowel physiology that are 
most relevant to explain the functional digestive 
disorders, i.e. sensation and motility aspects. The 
factors affecting the occurrence of IBS include 
dysmotilities, visceral hypersensitivity, post 
infection, food intake, changes in intestinal 
microbiota, genetics, and psychosomatic factors. 
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